Narayan Malathi, Seeley Kent W, Jinwal Umesh K
Department of Pharmaceutical Sciences, College of Pharmacy, Byrd Alzheimer's Institute, University of South Florida-Health, 4001 E. Fletcher Ave, MDC36, Tampa, FL 33613, United States.
Florida Center of Excellence for Drug Discovery & Innovation at the University of South Florida, 3720 Spectrum Blvd., Suite 303, IDR Building, Tampa, FL 33612, United States.
J Ethnopharmacol. 2015 Dec 4;175:86-92. doi: 10.1016/j.jep.2015.09.024. Epub 2015 Sep 24.
Withaferin A (WA) is a major bioactive compound isolated from the medicinal plant Withania somnifera Dunal, also known as "Ashwagandha". A number of published reports suggest various uses for WA including its function as an anti-inflammatory and anti-angiogenic drug molecule. The effects of WA at the molecular level in a cellular environment are not well understood. Knowledge of the molecular mechanism of action of WA could enhance its therapeutic value and may reveal novel pathways it may modulate.
In order to identify and characterize proteins affected by treatment with WA, we used SILAC- based proteomics analysis on a mouse microglial cell line (N9), which replicates phenotypic characteristics of primary microglial cells.
Using stable isotope labeling of amino acids in cell culture (SILAC) and mass spectrometry (MS), a total of 2300 unique protein groups were identified from three biological replicates, with significant expression changes in 32 non-redundant proteins. The top biological functions associated with these differentially expressed proteins include cell death and survival, free radical scavenging, and carbohydrate metabolism. Specifically, several heat shock proteins (Hsps) were found to be upregulated, which suggests that the chaperonic machinery might be regulated by WA. Furthermore, our study revealed several novel protein molecules that were not previously reported to be affected by WA. Among them, annexin A1, a key anti-inflammatory molecule in microglial cells was found to be downregulated. Hsc70, Hsp90α and Hsp105 were found to be upregulated. We also found sequestosome1/p62 (p62) to be upregulated. We performed Ingenuity Pathway Analysis (IPA) and found a number of pathways that were affected by WA treatment.
SILAC-based proteomics analysis of a microglial cell model revealed several novel proteins whose expression is regulated by WA and probable pathways regulated by WA.
睡茄素A(WA)是从药用植物睡茄(Withania somnifera Dunal)中分离出的一种主要生物活性化合物,睡茄也被称为“印度人参”。许多已发表的报告表明WA有多种用途,包括其作为抗炎和抗血管生成药物分子的功能。WA在细胞环境中的分子水平作用尚不清楚。了解WA的分子作用机制可以提高其治疗价值,并可能揭示其可能调节的新途径。
为了鉴定和表征受WA处理影响的蛋白质,我们在小鼠小胶质细胞系(N9)上使用基于稳定同位素标记氨基酸的细胞培养(SILAC)蛋白质组学分析,该细胞系复制了原代小胶质细胞的表型特征。
使用细胞培养中的氨基酸稳定同位素标记(SILAC)和质谱(MS),从三个生物学重复中总共鉴定出2300个独特的蛋白质组,32个非冗余蛋白质有显著的表达变化。与这些差异表达蛋白质相关的主要生物学功能包括细胞死亡和存活、自由基清除和碳水化合物代谢。具体而言,发现几种热休克蛋白(Hsps)上调,这表明伴侣机制可能受WA调节。此外,我们的研究揭示了几种以前未报道受WA影响的新型蛋白质分子。其中,小胶质细胞中的关键抗炎分子膜联蛋白A1被发现下调。发现热休克同源蛋白70(Hsc70)、热休克蛋白90α(Hsp90α)和热休克蛋白105(Hsp105)上调。我们还发现聚集体蛋白1/p62(p62)上调。我们进行了 Ingenuity 通路分析(IPA),发现了许多受WA处理影响的通路。
基于SILAC的小胶质细胞模型蛋白质组学分析揭示了几种其表达受WA调节的新型蛋白质以及WA可能调节的通路。